No.97 January 9, 2012

Exploratory study
Confirmatory study
Superiority study
Non-inferiority study
Equivalence study
Bioequivalence study
Parallel-group comparative study
Active placebo-controlled study

Clinical studies conducted to explore the characteristics of drugs (investigational drugs: 治験薬) are called exploratory clinical studies (探索的試験). PII clinical trials, which are conducted for preliminary evaluation of the safety, efficacy and pharmacokinetic profile (薬物動態) in a limited number of...

To read the full story


By Izuru Ando

While Japan has now granted its first emergency approval to Shionogi’s COVID-19 pill Xocova (ensitrelvir), the drug failed to win a unanimous vote by advisory panels, with skepticism lingering over its actual efficacy. To prep for the next emergency, which…

By Philip Carrigan

As the year 2022 draws to a close, what are managers thinking at the world’s leading pharmaceutical companies and medical device companies? We surveyed 86 managers at these companies to find out what’s on their minds.For many managers, a common…

A Japanese reimbursement policy panel on November 16 saw a continued scuffle between members representing healthcare providers and payers over…

Deloitte Tohmatsu Consulting proposed three drug pricing schemes designed to trigger the consolidation of generic makers on October 27, offering…

Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…

Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…